Results 351 to 357 of about 35,065 (357)

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Clinical Gastroenterology and Hepatology, 2019
Elisabetta Degasperi, Roberta D'ambrosio, Massimo Iavarone   +2 more
exaly  

The Era of Direct-Acting Antivirals Has Begun: The Beginning of the End for HCV?

Seminars in Liver Disease, 2011
exaly  

Optimal therapy of HIV/HCV co‐infected patients with direct acting antivirals

Liver International, 2015
exaly  

Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues

Expert Review of Gastroenterology and Hepatology
Fabienne Marcellin, Perrine Roux, Camelia Protopopescu   +2 more
exaly  

Direct-acting antivirals safe in elderly patients

Reactions Weekly, 2016
openaire   +1 more source

Tacrolimus/unspecified direct acting antivirals interaction

Reactions Weekly, 2018
openaire   +1 more source

Risk of HBV reactivation with direct-acting antivirals

Reactions Weekly, 2016
openaire   +1 more source